GYRONasdaqOpeators of Nonresidential BuildingsUS GAAP · USD

Gyrodyne, LLC

Gyrodyne, LLC is a U.S. real estate company in liquidation that owns and manages a small portfolio of nonresidential properties, primarily Flowerfield and Cortlandt Manor. Its current business is to preserve, entitle, and sell those assets in a way that maximizes proceeds for shareholders before dissolving the company.

Liikevaihto1,8milj. USD
Nettotulos−2,5milj. USD

Tilikausi 2015 · muutos edellisvuodesta

Kehitys 2015–2015

0,00,51,01,52,0milj. USD2015: 1,8 milj. USD20151,8
LiikevaihtoLiikevoitto (EBIT)

Liiketoiminta

Osuus liikevaihdosta
Real estate operations35 %

Rental and property management activities tied to the company's remaining operating properties.

Property entitlement and enhancement20 %

Zoning, subdivision, and site plan work intended to increase the realizable value of land parcels.

Asset disposition35 %

Strategic sale of Flowerfield, Cortlandt Manor, and other real estate assets.

Liquidation and wind-down activities10 %

Administrative and legal work associated with settling liabilities and preparing for dissolution.

Asiakkaat

Gyrodyne's direct customers are tenants and prospective property buyers rather than end consumers. Its tenant base supports interim cash flow while the company works through approvals and sales, and its buyers are typically real estate developers or users seeking entitled land or medical-oriented property. The company also has an indirect customer-like constituency in its shareholders, because the end goal is to return liquidation proceeds to them.

Commercial tenants

Lease space in Gyrodyne's properties to support occupancy and interim rental cash flow.

Real estate developers

Buy land or improved parcels, especially where subdivision and entitlements can unlock higher value.

Medical and mixed-use occupiers

Potential users of Cortlandt Manor's medical-oriented zoning and limited retail component.

Shareholders

Receive residual cash distributions after liabilities are settled and assets are sold.

Strategia

Gyrodyne's strategy is to maximize the value of its remaining real estate before liquidation by pursuing entitlements, subdivision approvals, and selective property enhancements. It is also trying to manage occupancy and lease cash flow while negotiating sales that may be either individual lots or whole parcels, depending on which path produces the best value and timing.

Secure approvals for Flowerfield dispositionLyhyt aikaväli

Subdivision and site plan approvals are required to close the pending sale and unlock value.

Enhance Cortlandt Manor through zoning entitlementsKeskipitkä aikaväli

The medical-oriented zoning district can improve the property's highest-and-best-use value.

Complete liquidation and dissolutionKeskipitkä aikaväli

The company intends to sell remaining assets, settle claims, and return cash to shareholders.

Maantiede

Gyrodyne's operations are concentrated in the United States, with its key assets in New York. The company specifically references Flowerfield and Cortlandt Manor, and its value realization depends on local zoning, subdivision, and site plan approvals from New York authorities. Geography matters because the liquidation timeline and sale price are heavily influenced by local entitlement outcomes.

Riskit

Gyrodyne's biggest risk is execution risk around approvals and asset sales: if subdivision, site plan, or other governmental approvals are delayed or denied, the liquidation timeline and proceeds could be materially affected. The company also faces ongoing operating losses, limited cash runway, activist shareholder disputes, and valuation uncertainty because liquidation accounting depends on estimates of asset values and liabilities.

Järjestetty vakavuuden mukaan
MatalaKohtalainenKorkeaMatalaKohtalainenKorkeaVaikutus →Todennäköisyys →Approval risk for Flowerfield sale1Liquidity and runway risk2Valuation and liability uncertainty in liquidation3Activist shareholder disruption4
Vaikutus on riskin vakavuus ja todennäköisyys sen toteutumisen todennäköisyys lähivuosina, molemmat arvioitu yhtiön raporttien perusteella. Numerot vastaavat listaa.
  1. Approval risk for Flowerfield saleVaikutus: KorkeaTodennäköisyys: Korkea

    The transaction is contingent on subdivision and site plan approvals outside management's control.

    Kohdistuu: Flowerfield property sale

  2. Liquidity and runway riskVaikutus: KorkeaTodennäköisyys: Korkea

    The company expects continued operating losses and has limited cash absent additional asset sales.

    Kohdistuu: Wind-down operations

  3. Valuation and liability uncertainty in liquidationVaikutus: KorkeaTodennäköisyys: Korkea

    Net assets in liquidation depend on estimates of real estate value and unknown liabilities.

    Kohdistuu: Liquidation distributions

  4. Activist shareholder disruptionVaikutus: KeskitasoTodennäköisyys: Korkea

    Proxy contests and governance disputes can consume time and money and complicate execution.

    Kohdistuu: Board and strategic process

Kirjanpito

Harkinnanvaraiset erät
Liquidation basis of accounting

The company reports net assets in liquidation and changes in net assets because dissolution is considered imminent.

Vaikutus: Changes the presentation from earnings to estimated distributable value

Fair value remeasurement of real estate

Property values are updated as sale expectations and entitlement outcomes change.

Vaikutus: Can materially increase or decrease net assets in liquidation

Provision for liabilities and liquidation costs

The company must estimate legal, severance, D&O tail, and other wind-down costs.

Vaikutus: Reduces expected cash available for shareholder distributions

Julkisesti listattuja yhtiöitä, joilla on samankaltainen liiketoiminta.

Päivitetty: 24.9.2026